Management of iron deficiency anemia in inflammatory bowel disease – a practical approach

por Stein, Jürgen, Dignass, Axel U.
Publicado 2013

Join the myUEG community and become an official myUEG Associate for free

por Dignass, Axel, Cortez‐Pinto, Helena
Publicado 2021

Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions

por Dignass, Axel, Farrag, Karima, Stein, Jürgen
Publicado 2018

Letter: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark

por Aksan, Ayşegül, Dignass, Axel, Stein, Jürgen
Publicado 2019

Psychosocial distress in acute cancer patients assessed with an expert rating scale

por Senf, Bianca, Brandt, Holger, Dignass, Axel, Kleinschmidt, Rolf, Kaiser, Jochen
Publicado 2010

Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective

por Domènech, Eugeni, Grífols, Joan-Ramon, Akbar, Ayesha, Dignass, Axel U
Publicado 2021

Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle

por Paclik, Daniela, Danese, Silvio, Berndt, Uta, Wiedenmann, Bertram, Dignass, Axel, Sturm, Andreas
Publicado 2008

Selective Non-Steroidal Glucocorticoid Receptor Agonists Attenuate Inflammation but Do Not Impair Intestinal Epithelial Cell Restitution In Vitro

por Reuter, Kerstin C., Loitsch, Stefan M., Dignass, Axel U., Steinhilber, Dieter, Stein, Jürgen
Publicado 2012

Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa: Therapie chronisch entzündlicher Darmerkrankungen in der COVID...

por Grunert, Philip C., Dignass, Axel, Kucharzik, Torsten, Stallmach, Andreas, Sturm, Andreas, Schmidt, Carsten
Publicado 2020

Chronic intestinal failure and short bowel syndrome in Crohn’s disease

por Aksan, Aysegül, Farrag, Karima, Blumenstein, Irina, Schröder, Oliver, Dignass, Axel U, Stein, Jürgen
Publicado 2021

Characteristics, clinical outcomes and patient-reported outcomes of patients with ulcerative colitis receiving tofacitinib: a real-world survey in the United States and five Europe...

por Armuzzi, Alessandro, Hart, Ailsa, Cappelleri, Joseph C., Mammar, Nadir, Hur, Peter, Hoskin, Benjamin, Hennessy, Fritha, Milligan, Gary, Dignass, Axel
Publicado 2023

Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort

por Kubesch, Alica, Rueter, Laurenz, Farrag, Karima, Krause, Thomas, Stienecker, Klaus, Hausmann, Johannes, Filmann, Natalie, Dignass, Axel, Stein, Jürgen, Blumenstein, Irina
Publicado 2019

Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease

por Schreiber, Stefan, Dignass, Axel, Peyrin-Biroulet, Laurent, Hather, Greg, Demuth, Dirk, Mosli, Mahmoud, Curtis, Rebecca, Khalid, Javaria Mona, Loftus, Edward Vincent
Publicado 2018

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

por Danese, Silvio, Hart, Ailsa, Dignass, Axel, Louis, Edouard, D'Haens, Geert, Dotan, Iris, Rogler, Gerhard, D'Agay, Laurence, Iannacone, Claudio, Peyrin-Biroulet, Laurent
Publicado 2016

Malignancy rates in Crohn's disease patients with perianal fistula: A German retrospective cohort study

por Podmore, Bélène, Beier, Dominik, Burisch, Johan, Genestin, Elisabeth, Haeckl, Dennis, Nagel, Oliver, Qizilbash, Nawab, Schwartz, David A., Vavricka, Stephan R., Bennett, Dimitri, Dignass, Axel
Publicado 2023

Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions

por Dubinsky, Marla, Bleakman, Alison Potts, Panaccione, Remo, Hibi, Toshifumi, Schreiber, Stefan, Rubin, David, Dignass, Axel, Redondo, Isabel, Gibble, Theresa Hunter, Kayhan, Cem, Travis, Simon
Publicado 2023

The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune‐Mediated Inflammatory Disease

por Müller-Ladner, Ulf, Dignass, Axel, Gaffney, Karl, Jadon, Deepak, Matucci-Cerinic, Marco, Lobaton, Triana, Carron, Philippe, Gisbert, Javier P., Pande, Ira, Utzinger, Maximilian, Addison, Janet
Publicado 2023

Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologic...

por Dignass, Axel, Akbar, Ayesha, Hart, Ailsa, Subramanian, Sreedhar, Bommelaer, Gilles, Baumgart, Daniel C., Grimaud, Jean-Charles, Cadiot, Guillaume, Makins, Richard, Hoque, Syed, Bouguen, Guillaume, Bonaz, Bruno
Publicado 2016

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis

por Magro, Fernando, Moreira, Paula Leão, Catalano, Gaia, Alves, Catarina, Roseira, Joana, Estevinho, Maria Manuela, Silva, Isabel, Dignass, Axel, Peyrin‐Biroulet, Laurent, Danese, Silvio, Jairath, Vipul, Dias, Claudia Camila, Santiago, Mafalda
Publicado 2023

iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis

por D’Amico, Ferdinando, Magro, Fernando, Caron, Benedicte, Dignass, Axel, Jairath, Vipul, Hart, Ailsa, Kotze, Paulo Gustavo, Paridaens, Kristine, Awadhi, Sameer Al, Kobayashi, Taku, Siegmund, Britta, Peyrin-Biroulet, Laurent, Danese, Silvio
Publicado 2023